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Abstract
In-vivo observation of the human retina at the cellular level is crucial to detect the first signs of 
retinal diseases and properly treat them. Despite the phenomenal advances in adaptive optics (AO) 
systems, clinical imaging of many retinal cells is still elusive due to the low signal-to-noise ratio 
induced by transpupillary illumination.
We present a transscleral optical phase imaging (TOPI) method, which relies on high-angle 
oblique illumination of the retina, combined with AO, to enhance cell contrast. Examination of 
eleven healthy volunteer eyes, without pupil dilation, shows the ability of this method to produce 
in-vivo images of retinal cells, from the retinal pigment epithelium to the nerve fibre layer. This 
method also allows the generation of high-resolution label-free ex-vivo phase images of flat-
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mounted retinas. The 4.4°x 4.4° field-of-view in-vivo images are recorded in less than 10 seconds, 
opening new avenues in the exploration of healthy and diseased retinas.
Introduction
Retinal diseases are the major cause of blindness in industrialized countries. For example, an 
estimated total of 196 million people will be affected by age related macular degeneration in 
20201. While tremendous effort is being made to develop novel therapeutic strategies to 
rescue retinal neurons and the Retinal Pigment Epithelium (RPE), optimal means for 
evaluating the effects of such treatments are still missing. The instruments used in eye 
clinics for routine eye fundus examination are not able to observe the minute changes in cell 
morphology that are present during early stages of the disease degenerative process.
The retina is an intricate and complex tissue composed of many layers. Individual cell 
imaging is very challenging due to many constraints such as ocular aberration reducing 
lateral resolution, eye motion artefacts and the lack of contrast of transparent cells. Another 
limitation is that most of the light entering the pupil is either absorbed or reflected at the 
photoreceptor segments interface2,3, overwhelming the weak signal back-scattered from the 
neuronal or RPE cells. The photoreceptor signal is maximum for an illumination beam 
entering the eye pupil centre and decreases sharply when entering at its edge. This angular-
dependent reflection of the retina is commonly referred as optical Stiles-Crawford effect 
(SCE)3.
The light reflected by the photoreceptors renders their observation possible using adaptive 
optics (AO) to correct ocular aberrations combined with flood illumination4–8 optical 
coherence tomography (OCT)9 or scanning laser ophthalmoscopy (SLO)10. In recent works, 
optical methods to observe the neuroretina and the RPE cells were proposed using AO-SLO 
with offset aperture11–14, split detector15,16, darkfield17, autofluorescence18, or AO-
OCT9,19. Despite the high-quality results obtained, these methods suffer either from a very 
small field-of-view (FOV), a lack of image clarity, safety concerns or an acquisition time too 
long for a clinical use.
Here, we propose a modality, called transscleral optical phase imaging (TOPI) that provides 
cellular-resolution label-free high-contrast images of the retinal layers over a large FOV 
without the drawback of a long exposure time. This method is based on transscleral flood 
illumination of the retina, which greatly increases the signal to noise ratio (SNR) of many 
retina structures as compared to trans-pupillary illumination. The light transmitted through 
the sclera creates an oblique illumination of the posterior retina, that is then imaged using a 
trans-pupillary AO full-field camera system. We demonstrate in healthy volunteers without 
pupil dilation that TOPI provides images of RPE cells and other retinal structures and 
enables cell quantification. We also demonstrate the potential of this technology on ex vivo 
samples using an experimental phase microscope with parameters similar to those of the in 
vivo apparatus. We show that label-free phase images of the cells in thick retina samples are 
matching the quality of confocal fluorescence microscopy.
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Transscleral illumination of the fundus produces an oblique beam that reaches the posterior 
layers of the eye (Fig. 1). The sclera transmits about 30% of the incident light when using 
near-infrared (NIR) light20, and the absorption and reflectance of the RPE-choroid complex 
vary with its pigmentation21,22. While crossing the sclera, the illumination light is scattered 
and diffused, producing a uniform highly divergent beam that reaches obliquely the posterior 
retina and illuminates it evenly.
Transscleral illumination presents two interesting properties that increase the low contrast of 
the retina observed with trans-pupil flood illumination. Firstly, due to the SCE, almost no 
high angle transscleral illumination light is coupled into the photoreceptors, allowing a large 
fraction of the light to reach the RPE layer. Secondly, no direct backscattered illumination 
light is collected by the imaging system because there is no overlap with the collection path 
located through the pupil. Thus, only the light multiply scattered by the different retina 
layers enters the optical system and reaches the camera, providing a darkfield imaging 
condition. The illumination angle is much larger than what is obtainable via illumination 
through the pupil, creating a non-uniform excitation of the retina spatial frequencies which 
enhances the contrast of transparent objects23,24.
Description of the TOPI camera
The optical diagram of the TOPI camera is shown in Fig. 2. The system combines 
transscleral illumination of the retina with a flood illumination AO fundus camera25. Two 
NIR (wavelength, λ=810 nm) light emitting diodes (LED), located on the nasal and 
temporal side of the eye, are imaged on the sclera surface and produce the transscleral 
illumination (Fig. 2b).
The rest of the system is composed of an AO closed-loop for ocular aberration correction, a 
camera (2D array detector, complementary metal oxide semiconductor (CMOS)) conjugated 
to the pupil for alignment purpose, a fixation target for retina location stabilization, and a 
scientific grade camera (sCMOS) for recording the high-resolution retina images. The 
details of the components used in the system are provided in the Materials and Methods 
section.
In vivo imaging of the RPE
The RPE layer image from a healthy volunteer taken with TOPI is exemplified in Fig. 3a 
(see Supplementary Fig. 1 for images in two additional volunteers). Due to the low SNR of 
the raw images coming from the retina, the in-vivo TOPI image was processed using a 
recorded sequence of 100 images taken within a total acquisition time of 9 seconds. The 
processing procedure of the sequence leading to a final image is described in the Materials 
and Methods section. Individual RPE cells are clearly visible on the full image with a dark 
centre and bright edges due to the absorbing pigments in the cell soma. The low reflectivity 
of the cone mosaic caused by the high angle illumination is not shadowing the signal from 
the RPE cells underneath. Due to the large depth-of-field (~30 μm), a lower spatial 
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frequency bright-and-dark “cloudy” modulation is partially overlapping the RPE cell 
mosaic. This unwanted signal is coming from the non-uniform pigmentation of the 
epithelium and from the out-of-focus light scattered from the choroid17. This modulation 
can be partially removed by post-processing the final image with a high-pass filter, as 
illustrated in the magnified inset (Fig. 3b).
Fig. 3a illustrates the wide field-of-view image (4.4°×4.4°) obtained with the TOPI system 
in less than 10 seconds while providing cellular resolution. In comparison, an AO-OCT 
system of similar spatial resolution has a significantly smaller field of view of 1.5°x1.5° and 
takes several minutes to obtain a similar image19.
The system allows imaging over a range of ±15° both vertically and horizontally 
(Supplementary Fig. 2). The SNR analysis performed on a sequence of raw images shows 
that an acquisition time as low as two seconds provides a suitable TOPI image for RPE 
quantification (Supplementary Fig. 3).
RPE cells size and density
RPE imaging was performed in eleven healthy volunteers (from 19 to 49 years-old). No 
major difference was noticed in the RPE images from the subjects with different skin 
pigmentations, demonstrating that TOPI could be used in patients of different phototypes26. 
The RPE cells quantification between 2° and 12° eccentricity gives an average area of 241 ± 
29 μm2 (Supplementary Fig. 4A) for an average density of 4371 ± 460 cells/mm2 
(Supplementary Fig. 4B). Interestingly, the youngest participant presented the highest 
density of RPE cells, whereas the oldest participant presented the lowest density 
(Supplementary Fig. 4C).
This quantitative analysis matched the values found in the literature at these 
eccentricities9,19. One in-vivo autofluorescence AO-SLO study provided a RPE cell density 
of 5890 cells/mm2 (168 μm2 area) and 5630 cells/mm2 (195 μm2 area) at 5° and 6.25° 
respectively (2 subjects)27. Another AO-OCT study reported a mean density at 3° of 4975 ± 
651 cells/mm2 (6 subjects)19. Scoles et al. reported, from histological study in the macula, 
an average density of 5662 cells/mm2 and an average cell area of 160 μm2 for age below 60 
(6 samples)28. These in-vivo and ex-vivo densities represent no significant difference with 
our data (probability value, P>0.05). Moreover, the row to row spacing of 13.8 μm extracted 
from Fourier analysis of the images (Supplementary Fig. 5) is the same as a previously 
reported value obtained with AO-OCT19.
In-vivo imaging of the nerve fibre layer (NFL)
By axially shifting the focal plane of the imaging system, other layers of the neuroretina can 
be observed (Fig. 4b-f). The location of each image is shown on the SLO fundus view (Fig. 
4a). Images of the vascular layer (Fig. 4b,c) show that retinal capillaries as small as few-
microns can be seen. The NFL is imaged at different eccentricities (Fig. 4d-f) where large 
axon bundles of 30-50 μm diameter are clearly visible and well-aligned in the direction of 
the optic nerve. The ability to observe very small capillaries and axons bundles comes from 
the dark-field effect of the transscleral illumination where the signal of the translucent 
structure is not buried under the illumination light.
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Comparison between transscleral and transpupillary illumination
The influence of the transscleral illumination on cell contrast is better understood by direct 
comparison with convention transpupillary illumination. A commercial AO retinal camera 
(model rtx1™, Imagine Eyes), using flood transpupillary illumination was compared with 
the TOPI camera, using transscleral oblique illumination. Three layers located at different 
depths were imaged using both instruments, over the same area of the subject S10’s fundus. 
Inner retina images (Fig. 5a,d) show the darkfield effect of the transscleral illumination with 
a bright vessel on a darker background. The transpupillary illumination in rtx1™ allows 
better visualization of the photoreceptors than TOPI images (Fig. 5b,e). This is due to the 
optical SCE at the inner-outer segment interface which provides a high reflectivity when 
light is incident perpendicular to the retina6. However, the strong cone signal produced by 
transpupillary illumination masks the adjacent layers, particularly the posterior RPE where 
only defocused photoreceptor light is visible (Fig. 5c). On the contrary, with transscleral 
illumination, cones produce a very weak signal, and thus the RPE cells appear well-
contrasted (Fig. 5f). These results clearly confirm the very interesting properties of 
transscleral illumination for imaging the deepest layer of the retina.
Oblique illumination for optical phase imaging microscopy
To validate the potential of oblique illumination to observe retina tissues, we developed a 
custom microscope with parameters similar to those of in-vivo imaging (Supplementary 
Note 1, Supplementary Fig. 6). Images of flat-mounted retinas obtained with this optical 
phase imaging (OPI) microscope are free of in vivo problems such as eye movements and 
aberrations. Using multiple illumination points, quantitative phase information was extracted 
from the ex vivo samples (for details see the Materials and Methods section). Through a 
comparative study with other common microscopy techniques, we demonstrated the 
quantitative property and the high contrast of phase images, as well as the potential of this 
modality to observe the retinal cellular structures (Supplementary Note 2, Supplementary 
Fig. 7). In addition, cell counting was possible on all phase images of the layers of a 200μm-
thick pig retina (Supplementary Note 3, Supplementary Fig. 8).
The OPI microscope was also equipped with high NA (0.4 or 0.65) objectives to perform 
high resolution phase imaging. We observed rat retinal capillaries and their surrounding 
cells, in a correlative study between phase microscopy and fluorescence confocal 
microscopy, using vessels as landmarks. After specific labelling of the pericytes in a healthy 
retina, the comparison of both modalities demonstrates that OPI modality allows for the 
detection of pericytes, appearing as bright cells around retinal capillaries (Fig. 6a) exactly at 
the same location of the pericytes labelled in green in the fluorescence images (Fig. 6b-c). 
The nuclei counter-staining (Fig. 6c, in blue) shows that the proposed phase imaging method 
also allows for high contrast imaging of the nuclei. After specific labelling of microglial 
cells in a diseased retina presenting a dystrophy associated with telangiectasias29, the image 
correlation analysis between phase (Fig. 6d) and confocal (Fig. 6e, green) microscopy 
unequivocally demonstrates that high resolution phase imaging allows for the detection of 
these small cells as well.
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Currently, the standard of care for retinal imaging is based on OCT and SLO. The first 
commercially available device integrating AO was based on flood illumination (rtx1™, 
Imagine Eyes). We describe herein a novel microscopy concept and instrument for fast in-
vivo imaging of the retinal pigment epithelium with high contrast and cellular resolution.
To our knowledge, no other imaging system allows for the visualization of RPE cells within 
a few seconds. We see no technological barriers to create an easy-to-use clinical instrument 
because transscleral illumination requires the same accuracy in terms of beam alignment 
than transpupillary systems. On the contrary, for cellular-resolution imaging, AO-SLO and 
AO-OCT would be more difficult to implement in clinical setting. As presented in 
Supplementary Table 1, their FOV of 2°×2° is close to five times smaller than the current 
TOPI system FOV. Five times more images would be required to cover the same clinically 
relevant FOV. Moreover, the use of a non-scanning system makes the acquisition process 
more stable under the effects of eye motion, especially because AO-SLO and AO-OCT 
require measurement time of several minutes. For the latter, eye-motion artefacts become a 
problem, which is much less the case for a flood-illumination system, in which all the pixels 
composing the image are recorded simultaneously with a few-milliseconds acquisition time.
The speed of an eye examination is crucial for patient’s comfort and becomes even more 
important when fixation capacity is reduced by retinal disease. The typical scan time for 
commercial clinical devices is a few seconds (2–3 s for Canon OCT-HS100, 2 s for Imagine 
Eyes rtx1™, 3 s for Optovue AngioVue, 19–38 ms for B-Scan for Heidelberg Spectralis 
OCT, and 2 s for Zeiss Cirrus HD-OCT). With less than ten seconds required for TOPI 
acquisition, the obtained contrast was sufficient to perform quantitative analyses on RPE 
cells. The full field flood imaging technique combined with transscleral illumination 
establishes an imaging modality that is several orders of magnitude faster than the AO-OCT 
technique when applied to weakly reflecting cells9,19. This difference is essentially due to 
the fact that TOPI uses the scattered light from the back of the eye, which is much more 
reflective than the transparent cells.
The light radiant exposure at the imaged area of the retina is comparable with existing 
technologies. For TOPI imaging, a single raw image requires an estimated radiant energy of 
79 μJ/cm2 at the retina, while the 100-images sequence needed to obtain the final image 
yields 7.9 mJ/cm2. These values are similar to those of the commercial flood illumination 
device rtx1™ 6 and are lower than those used in a scanning system based on SLO or OCT 
(comparison with other AO imaging methods in Supplementary Fig. 9). The projected spot 
on the sclera has a power density that satisfies the safety standard for skin and ocular tissues 
(see the Materials and Methods section). We note that, in all previous studies related to high-
resolution imaging of the retina, averaging of raw data is also necessary to obtain high SNR.
In the present study, in-vivo examinations of eleven healthy volunteers with our TOPI set up 
demonstrated the feasibility of fast imaging of RPE cells but also the possibility of 
quantifying them accurately. As only one fundus area was observed in most subjects, more 
studies will be needed in order to confirm if RPE cells are visible with TOPI across the full 
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accessible FOV for every subject. Importantly, the quality of RPE images was not impaired 
by individual skin phototypes and subsequent RPE pigmentation. TOPI examination also 
allowed accurate visualization of nerve fibre and vascular layers. Compared to images of 
retinal capillaries obtained with OCT angiography, the images of the smallest vasculature 
obtained with our method are independent of flow velocity and could thus provide 
complementary information.
The imaging modality can be easily adapted to a microscope and produce a powerful method 
to observe flat-mounted retina at the cellular level, without staining. Quantitative phase 
capability is obtained by combining multiple oblique illumination points and with 
appropriate modelling of the illumination function. For example, it allows the exploration of 
retinal capillaries and their surrounding cells.
The ability to image RPE cells within seconds in patients is of major interest to better 
understand the physiopathogenesis of retinal diseases and to follow the course of diseases 
that affect the RPE such as age-related macular degeneration (AMD), retinitis 
pigmentosa30,31, or diabetic retinopathy32. Decrease in cell density and change in cell 
morphology could potentially be detectable at the early stage of AMD, before any 
complication has occurred33,34. TOPI could also be used to detect effects of drugs and 
treatments at a cellular level, offering the opportunity to intervene before irreversible 
functional loss has occurred. Morphologic quantitative new endpoints could thus emerge. In 
addition, recent medical studies have shown that Parkinson’s and Alzheimer’s diseases have 
an effect on the neuronal layers of the retina35,36, which may increase the impact of the 
clinical use of this technology.
In summary, TOPI holds promise for clinical use because it is, to the best of our knowledge, 
the only technique fast enough to image the RPE with high contrast and cellular resolution. 
Further clinical studies will clarify the limitations of this new imaging modality particularly 
in diseased states that distort the retinal layers organization. TOPI could not only accelerate 
our understanding of retinal diseases and define new morphological endpoints for 
therapeutic evaluation, but also the understanding of other neuro degenerative diseases.
Materials and Methods
Study on human subjects
The single-centre study aimed at validating the performances of our phase imaging device 
adheres to the tenets of the Declaration of Helsinki. The protocol involving healthy human 
volunteer subjects was approved by the local Ethics Committee of the Swiss Department of 
Health on research involving human subjects (CER-VD N°2017-00976). Informed consent 
was obtained from the subjects. The left eyes of eleven healthy volunteers were imaged (four 
women, seven men) with an average age of 28 years (+/− 9) and having different skin 
pigmentations ranging from 1 to 6 on the Fitzpatrick scale were imaged26.
In vivo experimental design
The transscleral oblique illumination of the retina was produced using two Light Emitting 
Diodes (LED) with 810 nm nominal wavelength, 25 nm FWHM. The LED light beams are 
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focused on the sclera at the pars-plana region to the temporal and nasal side of the iris (Fig. 
2). The light beams can be operated at the same time or alternatively to capture images with 
one or two illumination points. The obtained angle of illumination for each point was 
therefore approximately 35°. The subject’s head and eye were aligned with the system using 
an adjustable chin and forehead rest.
The apparatus optical diagram is shown in (Fig. 2) and consisted in the following elements: 
The illumination arm was composed of a yellow fixation target, of a 756-nm 
superluminescent diode (SLD, Exalos), which provided a point source at the retinal plane for 
the aberration correction measurements, and of an 1050 nm low power infrared LED for 
illuminating the pupil uniformly. The imaging arm integrated a pupil camera (DCC3240M, 
Thorlabs), an AO feedback loop10 (Imagine Eyes Mirao 52e or Alpao DM97-15 deformable 
mirror and Imagine Eyes HASO4 wavefront sensor), and an sCMOS camera for imaging the 
retina (ORCA Flash 4.0, Hamamatsu). The retinal sCMOS camera collected the light 
coming from the transscleral illumination to image the eye fundus through the pupil with a 
lateral sampling of 0.7 μm/pixel.
TOPI images were acquired in healthy volunteers, in dark room conditions without pupil 
dilation. The pupil diameter ranged from 4 to 7 mm. Once the position of the eye was 
aligned on the setup thanks to a chin and forehead rest, the retinal camera, which was 
mounted on a translation stage, was adjusted to focus on the targeted retinal layer. The real-
time AO feedback loop was used for correcting the defocus accommodation of the eye (i.e., 
axial shifts of the plane), thus always locking a given imaging depth in the retina to a 
corresponding camera position. The depth sectioning is limited in this case by the depth of 
field, which is given by the pupil size and the aberrations of the eye. For instance, for an 
aberration-free-6-mm pupil, the depth of field is 27 μm, yielding a value of 0.17 NA (the 
equivalent focal distance of the eye lens in air is 17 mm), for a lateral resolution of 2.9 μm. 
A sequence of one or two hundred images at a given depth in the retina (100 with 
simultaneous points and 200 with alternate) was acquired by successively turning the LED 
spots ON and OFF with an exposure time of 8 ms and a repetition rate of 11 Hz per 
illumination point. The image focus can be made at any depth in the retina by introducing a 
quadratic phase shift (defocus term) on the deformable mirror. The maximum reflection 
point of the SLD probing beam is known to be at the photoreceptor layer. The defocus term 
is varied to reach a specific layer (such as RPE) and can be calibrated in advance by 
knowing the average distance between the photoreceptors and the layer of interest. The large 
depth of field (i.e. 27-100 μm, depending on pupil size) of our non-confocal technique allow 
to image the RPE even if the real distance is slightly different from the calibrated one. Each 
layer took 9 seconds to image. The raw images were then post-processed, as explained in the 
“in vivo image processing” section, to produce a single TOPI image.
Light safety analysis
The illumination beams are projected on the participant’s sclera when the eye is correctly 
aligned with the instrument. However, a complete safety analysis has to take into account 
any accidental projection of the beam on the skin, iris, cornea and lens to ensure no potential 
hazard of the system. To this end, the scleral, corneal, lens and retinal exposure were 
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measured or calculated and compared with their respective exposure limits. We used the 
limits as expressed in the international standards for ophthalmic instrument optical safety 
ISO 15004-2:2007 for the ocular tissue and the skin limits given in the 2013 ICNIRP 
Guidelines on limits of exposure to incoherent visible and infrared radiation.
Eye exposure conditions—The beam minimum diameter is 3.5 mm at its focus point on 
the eye and the full converging angle is 0.37 radian. The pulse length is 8 ms and the 
repetition rate 11 Hz (duty cycle of 0.088), with a measured pulse power of 250 mW at a 
centre wavelength of 810 nm with FWHM of 25 nm. The consecutive acquisition time is no 
longer than 10 seconds. Based on the measured power and pulse specification, the eye 
exposure is straightforward calculated:
Maximum pulsed irradiance at the sclera surface (8ms): EP = 2.598 W/cm2.
Scleral radiant exposure for single pulse (1 pulse, 8ms): H1 = 21 mJ/cm2
Time-average irradiance (11 Hz): EAV = 229 mW/cm2.
Scleral radiant exposure for maximum exposure time (110 pulses, 10s): H110 = 2.287 J/cm2
Retinal exposure—The light exposure reaching the underlying choroid and retina after 
crossing the sclera is less straightforward to compute. Only part of the light will transmit, 
and the beam will be scattered and spread by the tissue. The more accurate measurement on 
scleral transmission and absorption were done by Vogel et al. in 199120. They measured a 
~33% transmission (and ~5% absorption) for a wavelength of 810 nm. As a conservative 
estimate, we will assume no diffusion nor beam spreading, thus giving a retinal exposure of 
33% of the scleral exposure to compare with the limits.
The retinal irradiance in case of accidental trans-pupil illumination is calculated thanks to 
the beam converging angle. The retinal image diameter dr and surface A is:
dr = f ⋅ φ = 17 mm 0.37 radian = 6.29 mm A = 0.31cm2
The irradiance is then directly found: E = 250 mW/0.31 cm2 = 0.805 W/cm2. The irradiance 
of the posterior retina in case of accidental trans-pupil exposure (0.805 W/cm2) is smaller 
than the irradiance of the retina underlying the sclera in case of intended transscleral 
exposure (33% * 2.598 = 0.857 W/cm2). The transscleral exposure and not the accidental 
trans-pupil exposure is therefore the worst-case exposure scenario for the retina to compare 
with the limits.
Applicable limits for Group 1 pulsed instrument—Weighted retinal visible and 
infrared radiation radiant exposure limit:
For 1 pulse 8ms :HVIR‐R = 0.1605 J/cm2
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For 110 pulses 10s :HVIR‐R = 10.4184 J/cm2
Unweighted corneal and lenticular infrared radiation radiant exposure limit:
For 1 pulse 8ms :HIR‐CL = 0.5383 J/cm2
For 110 pulses 10s :HIR‐CL = 3.2009 J/cm2
Unweighted anterior segment visible and infrared radiation radiant exposure limit (for 
convergent beam only):
For 1 pulse 8ms :HVIR‐AS = 7.4767 J/cm2
For 110 pulses 10s :HVIR‐AS = 44.4570 J/cm2
Skin limits—
For 1 pulse 8ms :HSKIN = 0.5981 J/cm2
For 110 pulses 10s :HSKIN = 3.5566 J/cm2
The radiant exposure conditions of the eye for 1 pulse H1 and 110 pulses H110 calculated 
above can be directly compared with the different limits. They are below all limits for Group 
1 instrument (i.e. “ophthalmic instrument for which no potential light hazard exists”) as well 
as below the ICNIRP skin limits. The retina limits for our NIR exposure are not even 
attained if the sclera were considered with 100% transmission. The safety factor for retinal 
exposure is therefore at least a factor 20 (considering 33% transmission and thermal hazard 
weighting function R(λ)=0.6 for λ=810 nm).
The condition being the closest to the limit is the cornea and lenticular exposure in case of 
misalignment of the device, or a subject starring directly at the illumination beam. This 
event is very unlikely to happen but a safety factor of 1.5 prevent any potential adverse effect 
in that case.
No explicit limits are provided for the sclera in the ISO 15004-2:2007 or ICNIRP guidelines. 
However, limits are provided for the anterior segment (cornea and lens) and for the skin. The 
sclera tissue itself can be considered in between skin and cornea. As it has a similar 
absorption coefficient for NIR as the cornea (but more scattering)20, the sclera is expected to 
have a similar exposure limit. It is therefore reasonable to assume that sclera is safe if both 
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the anterior segment limits and the limits for the more pigmented tissues such as skin are not 
attained, which it is the case for our instrument. As an additional safety evidence, far larger 
radiant exposure was sent on the sclera by Geffen et al. without noticing any adverse 
effect37.
In vivo image processing
Because of sudden eye micro-saccades during the 8ms acquisition time, some raw images 
had motion-blur artefacts. Therefore, only the 80% sharpest images were automatically or 
manually selected for each illumination point based on the contrast criteria (std/mean). The 
images were then aligned in order to correct for the eye motions using the ImageJ plugin 
TurboReg, which considers the translations and the rotations of the images38. Once the raw 
images were aligned, averaging of the sequence produced a single high-SNR dark-field 
image for each illumination point for a specific layer. The two dark-field images were then 
summed to produce the final image. When the two illumination points are emitting together, 
only one dark field image of equivalent contrast is obtained. For visualization, the dark-field 
image was high-pass filtered (ImageJ bandpass filter with boundaries 1pixel-30pixels) and 
normalized with histogram stretching. The high-pass filter was used to remove a large part 
of the out-of-focus light.
Cell segmentation and quantification
Cell segmentation was performed on several retinal layers to obtain quantitative morphology 
and density values. For the RPE layer, an automatic segmentation was performed via local 
minimum detection. Then, the Voronoi filter function was applied to create equidistant cell 
contours between the two nearest maxima, leading to RPE segmentation. Voronoi mapping 
is commonly used to map the retinal soma mosaic9. The coefficient of variation (CoV)39, 
has been computed on subject S10 based on automatic RPE count and area measurements 
repeated five times under changed equipment and materials (two different deformable 
mirrors and two different head mounts were used) over five months. The results, plotted on 
Supplementary Fig. 10, give a CoV of 6.13% for RPE count and 6.44% for RPE area. This 
standard measurement characterizes the reproducibility of the acquisition. The resulting 
values are considered good for a prototype device since higher values of CoV can be 
measured on commercial devices39.
Statistical analysis
Results were expressed as mean ± standard deviation. Student’s t-test was used to compare 
our data with that of the literature, when possible. A P value of <0.05 was considered 
statistically significant.
Retinal ex-vivo samples
Flat-mounted retina-choroid complexes—The two human-donor eyes were obtained 
from the eye bank of the Jules-Gonin Eye Hospital, in conformity with the Swiss Federal 
law on transplantation. It was collected for research purpose at 10h post-mortem, fixed in a 
4% paraformaldehyde solution (PFA) for 24 h, and then stored in 1% PFA at +4°C until it 
was analysed. Pig eyes were obtained from a local slaughterhouse, a few hours after the 
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animals’ death. These eyes were fixed in 4% PFA for 24 h, and then stored in a phosphate-
buffered saline (PBS) at +4°C for one day before mounting.
After washing in PBS, the anterior segment of the eyes and the vitreous were removed. The 
retina-choroid complexes were detached from the remaining posterior segments, and flat-
mounted in a solution made of PBS-glycerol (1:1). The human retina-choroid complexes 
were observed using a confocal microscope (Zeiss LSM710). The human and pig samples 
were also observed using our experimental phase microscope (as illustrated in 
Supplementary Fig. 6D).
Cryosectioning—One pig eye was kept for cryosectioning. After fixation and 
microdissection, the posterior segment of the eye was snap- frozen prior to frozen sectioning 
on a microtome-cryostat. Frontal 10 um-thick sections were prepared and mounted on a 
glass coverslip. These sections were imaged using a digital holographic microscope 
(DHM)40 and then with our phase microscope.
Immunohistochemistry on neuroretinas—Two pigmented rats from the animal 
facility of the Jules-Gonin Eye Hospital were used. Investigations were performed in 
accordance of the Association for Research in Vision and Ophthalmology (ARVO) statement 
for the Use of Animals in Ophthalmic Vision Research. Our study was approved by the 
cantonal veterinary office (Authorization VD2928). Retinal morphology was examined in-
vivo, under ketamine / xylazine (80mg/kg and 8 mg/kg) anaesthesia and after dilation, using 
a spectral domain OCT system adapted for rat eyes (Bioptigen). Animals were sacrificed via 
pentobarbital injection. After enucleation and fixation of the whole eyes during 2 h in 4% 
PFA, the anterior segments were discarded and the neuroretinas were carefully separated 
from the remaining posterior segment. Post-fixation was carried out for 10 min at −20°C in 
acetone.
For pericytes immunostaining, after rehydration in PBS supplemented with 0.5% Triton 
X100 and 10% foetal bovine serum (FBS) overnight at +4°C, the retinas were incubated for 
two days at +4°C with polyclonal rabbit anti-NG2 antibodies (1:200; AB5320, Merk 
Millipore). For microglia immunostaining, after rehydration in PBS supplemented with 
0.5% Triton X100 and 10% FBS for 30 minutes at room temperature, the retinas were 
incubated overnight at +4 °C with a rabbit anti-iba1 (1:200; Wako) and a goat anti-collagen 
IV (1:100, Serotec) antibodies diluted in the same buffer. After washing, the neuroretinas 
were incubated with the appropriate antibody (Alexa-488-conjugated goat anti rabbit IgG, 
1:250; donkey anti-goat A633, 1:400; Invitrogen), diluted in PBS supplemented with 0.1% 
Triton X100 and 10% FBS, for 2 h at room temperature. After washing, the tissues were 
stained for 10 min with 4’, 6-Diamidino-2-Phenyl-Indole (DAPI, 1:10 000), washed again, 
and flat-mounted in PBS-glycerol (1:1). The neuroretinas were examined with a confocal 
microscope (Zeiss LSM 710), and then with our phase microscope.
Ex-vivo experimental design
Our experimental phase microscope is illustrated in Supplementary Fig. 6. A total of four 
different LEDs were placed equally spaced around a microscope objective to produce four 
different illumination points. The sample was placed below the microscope objective (MO) 
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and imaged using a CMOS camera using the MO and an achromatic doublet as a tube lens. 
A scattering layer of translucent commercial tape was used between each LED and the 
sample to increase the extent of illumination light and to mimic the scattering caused by the 
sclera. The sample was moved vertically to change the imaging layer depth. Depending on 
the NA of the MO, the exposure time varied between 1 ms and 20 ms. For each illumination 
point, a total of ten raw images were averaged to increase the SNR. A total of four averaged 
dark-field images (one for each points) were obtained for each depth. Then, the processing 
steps described below were carried out to produce either differential phase contrast (DPC) 
images or a single phase-contrast image.
Ex-vivo image processing and phase reconstruction
An image of the sample is recorded for each illumination point and a final quantitative phase 
image is reconstructed following the method described in a previous paper24. Phase images 
can be reconstructed using the following principle: at least two pictures with intensities I(α) 
and I(α+180), captured with two different symmetric illumination polar angles (α and α
+180°), are required. A DPC image can be then obtained according to:
IDPC =
I α − I α + 180∘
I α + I α + 180∘
.
Using several illumination points, multiple DPC images are produced. By combining these 
different DPC images of the same object, it is possible to obtain a quantitative phase image 
of the object thanks to the reconstruction process described in Tian and Waller’ study41. 
Finally, the reconstruction process of the phase is performed24,41,42. The reconstruction 
process is a Tikhonov regularization process with a known transfer function. The absorption 
transfer function is supposed to be identical for the different illumination points, meaning 
that it cancels out after the subtraction. The phase transfer function was calculated using the 
linearized imaging model presented by Tian and Waller41.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Illumination of the retinal layers provided via transscleral illumination.
(a) Light transmission into the eye. The light is first transmitted through the sclera, the retina 
pigment epithelium (RPE), and the neuroretina. After travelling through the vitreous humor 
and the retina, it impinges on the RPE layer. The light is multiply scattered by the RPE. A 
part travels back and propagates through the neuroretina and its translucent cells, the 
vitreous, the eye lens, and, then, the anterior segment of the eye. (b) Artistic illustration of 
the translucent vascular, neuronal and glial cells of the retina. (c) Histological cut of the 
retinal layers, the choroid, and the sclera. GCL: ganglion cells layer; INL: inner nuclear 
layer; IPL: inner plexiform layer; IS/OS: inner and outer segments of the photoreceptors; 
NFL: nerve fiber layer; ONL: outer nuclear layer; OPL: outer plexiform layer.
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Fig. 2. Optical diagram of the in vivo Transcleral Optical Phase Imaging system.
a) Transscleral light is produced by two 810nm LEDs focused on the sclera surface (one is 
shown). Light is then transmitted inside the eyeball. After scattering from the retinal cell 
layers, the light going out of the eye pupil is collected by the optical system. Other light 
sources are 940nm LED for pupil retro illumination, 780 nm SLD for aberration 
measurement and yellow 580nm LED for fixation target. The optical setup includes a pupil 
camera for alignment, a retinal camera to record fundus image and an adaptive optics loop to 
correct the aberration of the eye. DM: Deformable mirror; LED: light-emitting diode; SLD: 
superluminescent diode; WFS: wavefront sensor. P planes are eye pupil conjugated planes. 
R planes are retina conjugated planes. b) Illustration of transscleral illumination by the two 
810nm LED focused beams on the sclera.
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Fig. 3. In vivo full-field (4.4°x4.4°) image of the retinal pigment epithelium (RPE) of a healthy 
volunteer (left eye, subject S10) taken with TOPI at an eccentricity of 6.7° from the fovea.
(a) The RPE image is the average of 100 raw retinal images taken in 9 seconds to increase 
the SNR. A mosaic of RPE cells is visible where the individual cell somas appear dark due 
to the absorbing pigment within the cell body. The cells are partially masked under a lower 
spatial frequency background modulation with varying intensity, coming from the out-of-
focus signal from the choroid. Scale bar, 1° or 300 μm. Orange square shows the inset ”b” 
location. (b) The original RPE image is cropped and high-pass filtered to remove the out of 
focus light and have a more uniform cell mosaic (c) SLO fundus image showing the location 
of the TOPI image “a” (blue square).
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Fig. 4. Microcapillaries and nerve fiber layer TOPI images of subject S10 taken at different 
eccentricities.
Each 3°x3° field of view image is cropped from a full TOPI image for better visualization in 
the figure. Scale bar, 0.5° or 150 μm. (a) SLO fundus image showing the location of each 
TOPI image crop. (b-c) Microcapillaries being few microns thick are visible even if no 
blood flow is present thanks to the dark field effect of the oblique illumination. (d-e-f) Large 
axons bundles of 30-50 μm are clearly identifiable when looking at the nerve fiber layer. The 
bundles are well aligned and directed toward the optic nerve, as expected.
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Fig. 5. Comparison between in vivo images from a trans-pupil flood illumination commercial 
system (rtx1™, Imagine Eyes; Top) and a trans-scleral illumination TOPI image (Bottom) on the 
same area.
(a, b) In the inner retina (zrtx1=270 μm), the blood vessel appears light on dark background 
with TOPI due to the darkfield effect of oblique illumination. (b, e) At the photoreceptor 
level (zrtx1=20 μm), the cones appear hyper-reflective in the rtx1 image due to light coupling 
inside the cells (Stiles-Crawford effect). They are barely visible in the TOPI image because 
no reflection is produced by the oblique illumination. (c, f) At the RPE level (zrtx1=-200 
μm), on the rtx1 image, no RPE cells are visible because their signal is buried under the out-
of-focus photoreceptors light, whereas on the TOPI image, the RPE cell mosaic is visible. 
The somas appear dark because of the pigments composing the cells.
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Fig. 6. Image correlation analysis between oblique illumination optical phase imaging (OPI) 
microscopy and fluorescence confocal microscopy of retinal vessels and their surrounding cells.
(a-c) Pericytes visualization in a healthy retina from a 3-month-old rat. Cells highlighted 
with arrowheads in the phase image obtained under a 0.4-NA objective (a) were localized 
exactly where the NG2+ pericytes were detected in fluorescence images (in green, b-c). 
Nuclei are stained in blue (c). (d-e) Microglial cells visualization in a retina presenting 
retinal dystrophy from an 11-month-old rat. Phase images obtained under a 0.65-NA 
objective (d) were compared with fluorescence images (e) showing Iba1-positive microglia 
(in green) and collagen IV-positive vessels (in red). Magnifications of three cells in both 
imaging modalities illustrate the detection of microglial cells using the OPI modality (d). 
Ramified quiescent microglia and reactive microglia, with a round cell body (arrows), are 
shown. Scales bar, 50 μm.
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